Patents by Inventor Elie Hadchity

Elie Hadchity has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of squamous cell carcinoma with HSP27 antisense oligonucleotides and radiotherapy
    Patent number: 9381209
    Abstract: Squamous cell carcinomas, such as squamous head and neck cancer, are treated with a combination of radio-therapy and a therapeutic agent that reduces the amount of hsp27 in the squamous cancer cells. In specific embodiments, the therapeutic agent that reduces the amount of hsp27 is an antisense oligonucleotide therapeutic agent.
    Type: Grant
    Filed: March 4, 2008
    Date of Patent: July 5, 2016
    Assignee: The University of British Columbia
    Inventors: Claire Rodriguez-Lafrasse, Elie Hadchity
  • Treatment of Squamous Cell Carcinoma with HSP27 Antisense Oligonucleotides and Radiotherapy
    Publication number: 20100324115
    Abstract: Squamous cell carcinomas, such as squamous head and neck cancer, are treated with a combination of radio-therapy and a therapeutic agent that reduces the amount of hsp27 in the squamous cancer cells. In specific embodiments, the therapeutic agent that reduces the amount of hsp27 is an antisense oligonucleotide therapeutic agent.
    Type: Application
    Filed: March 4, 2008
    Publication date: December 23, 2010
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Claire Rodriguez-Lafrasse, Elie Hadchity